TY  - GEN
AU  - Cheng,Yu
AU  - Wang,Guo
AU  - Zhang,Wei
AU  - Fan,Lan
AU  - Chen,Yao
AU  - Zhou,Hong-Hao
TI  - Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers
SN  - 1432-1041
PY  - 2013///0801
KW  - Administration, Oral
KW  - Area Under Curve
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Asian People
KW  - Biomarkers
KW  - blood
KW  - Blood Glucose
KW  - drug effects
KW  - China
KW  - epidemiology
KW  - Cyclohexanes
KW  - administration & dosage
KW  - Cytochrome P-450 CYP2C9
KW  - Genotype
KW  - Half-Life
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Liver-Specific Organic Anion Transporter 1
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Nateglinide
KW  - Organic Anion Transporters
KW  - Pharmacogenetics
KW  - Phenotype
KW  - Phenylalanine
KW  - Polymorphism, Single Nucleotide
KW  - Prospective Studies
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00228-012-1364-9
ER  -